No Detail Found!

Application of urine immunofixation electrophoresis in prognostic evaluation of hematopoietic stem cell transplantation in patients with myeloma

Author(s)
Shanshan Zhu Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China.
Chao Yang Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China.
Wei Li Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China.
Meilin Lin Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China.
Abstract
Objectives: To investigate the value of urine immunofixation electrophoresis in prognostic evaluation of hematopoietic stem cell transplantation in patients with myeloma. Methods: Thirty-four patients with multiple myeloma admitted to Affiliated Hospital of Hebei University from November 2013 to December 2014 were included as research subjects. All patients received hematopoietic stem cell transplantation and were followed up for five years. Outcomes were evaluated according to the recovery status: complete response (CR), very good partial response (VGPR), partial response (PR), stable disease (SD), and progression disease (PD). In addition, the overall response rate (CR+VGPR) of patients was observed and their urine immunoglobulin status was measured by immunofixation electrophoresis. The Kaplan-Meier method was utilized to plot the survival curve, and the Log-rank method was adopted to analyze the relationship between CR+VGPR and PR and hematopoietic stem cell transplantation (HSCT) survival in patients with myeloma. Results: The basic clinical type of immunofixation electrophoresis was as follows: 19 cases (55.88%) of IgG, 7 cases (20.59%) of IgA, 6 cases (17.65%) of IgM, and 2 cases (5.88%) of light chain type. Outcomes: 13 cases (38.24%) of CR, 12 cases (35.29%) of VGPR, 9 cases (26.47%) of PR, and 25 cases (73.53%) of the overall response rate (CR+VGPR). Compared with IgG, CR, VGPR and PR of IgA, IgM and light chain had statistically significant differences in outcome (p<0.05), and CR+VGPR of patients with IgG was higher than that of patients with IgA, IgM and light chain type (p<0.05). Two of the 34 patients were lost to follow-up. The log-rank analysis showed that the survival rate of patients with CR+VGPR was higher than that of patients with PR (p<0.05). Patients with IgA, IgM, and light chain type had an increased number of prognostic death compared with those with IgG (p<0.05). Conclusion: Patients with IgG type myeloma are superior to those with IgA, IgM and light chain type in terms of the prognosis of hematopoietic stem cell transplantation, which has a certain clinical reference value.
Publication Details
Page(s) 315-319
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 38, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
prognosis, Multiple myeloma, Hematopoietic Stem Cell Transplantation, Urine, Immunofixation electrophoresis
0

Citations

0

Downloads

83

Views